" class="no-js "lang="en-US"> Oncology Archives - Medtech Alert
Wednesday, April 17, 2024

Sort by:

Date

Top Post

Roche’s Tecentriq Plus Avastin Reduced Risk of Cancer Returning in People with Certain Types of Adjuvant Liver Cancer in a Phase III Study

Roche has announced new data from the Phase III IMbrave050 study that show Tecentriq (atezolizumab) […]

Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic

Vyriad announces an expansion of a Phase 1 investigator-initiated trial at Mayo Clinic evaluating the […]

Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors

Alentis Therapeutics, the clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ […]

Future Fields and Jenthera Therapeutics Collaborate to Develop Novel Protein for the Delivery of Cancer Biologics

Future Fields, a pioneering biotechnology company that has built the world’s first synthetic biology system […]

Heligenics Unveils A First-Of-Its-Kind Precision Prescription Test For Breast Cancer Therapeutics

Heligenics, a cutting-edge biotech company, announces a first-of-its-kind precision genetic test to select among drugs […]

Thales Helps Lunit Accelerate the Growth of AI-based Software Cancer Diagnostic Solutions

Thales, a global leader in software monetization and licensing, is collaborating with Lunit, a global […]

Biostar Pharma Announces First Patient Enrolled for Phase 1 Study of Utidelone Capsule (UTD2)--The World's First Oral Epothilone Anti-Cancer Drug

Biostar Pharma, the US subsidiary of Beijing Biostar Pharmaceuticals which is a synthetic biology-driven biopharma […]

Lantern Pharma Receives FDA Clearance of IND Application for Drug Candidate LP-184 in Solid Tumors

Lantern Pharma, an artificial intelligence company developing targeted and transformative cancer therapies using its proprietary […]

Astellas Submits New Drug Application for Zolbetuximab in Japan

Astellas Pharma has announced the submission of a New Drug Application (NDA) on June 9, […]

Gilteritinib as Maintenance Therapy Demonstrated Benefit in Subgroups of FLT3-ITD Acute Myeloid Leukemia Patients

Astellas Pharma and the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) has presented […]

Genmab Showcases Data From Comprehensive Epcoritamab Development Program in Patients Across B-Cell Lymphomas

Genmab has announced data from its ongoing phase 1/2 EPCORE™ NHL-2 trial investigating epcoritamab, a T-cell […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more